King Hussein Cancer Center

Futó vizsgálatok

• Toboroz

  HYperfractionated Radiation Therapy Versus Concurrent Chemoradiation for Head and Neck Cancer (HYTC)

  NCT07801235· King Hussein Cancer Center· Forrás

• Toboroz

  Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors

  NCT06528691· 2. fázis· St. Jude Children's Research Hospital· Forrás

• Toboroz

  MB-CART19.1 in Relapsed/Refractory Acute Lymphoblastic Leukemia

  NCT07371403· King Hussein Cancer Center· Forrás

• Fut, nem toboroz

  P1101 in Treating Patients With Early PMF or Overt PMF at Low or Intermediate-1 Risk

  NCT06468033· 3. fázis· PharmaEssentia· Forrás

• Toboroz

  IMPACT-AML: A Randomized Pragmatic Clinical Trial for Relapsed or Refractory Acute Myeloid Leukemia.

  NCT06713837· 3. fázis· Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS· Forrás

• Toboroz

  Master Framework For Relapse or Refractory Acute Myeloid Leukemia

  NCT06459024· Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS· Forrás

• Fut, nem toboroz

  ARCHERY - Artificial Intelligence Based Radiotherapy Treatment Planning for Cervical, Head and Neck and Prostate Cancer

  NCT05653063· University College, London· Forrás

• Fut, nem toboroz

  A Study to Evaluate ABP 206 Compared With OPDIVO® (Nivolumab) in Subjects With Unresectable or Metastatic Melanoma

  NCT06054555· 3. fázis· Amgen· Forrás

• Toboroz

  A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer

  NCT05894239· 3. fázis· Hoffmann-La Roche· Forrás

• Fut, nem toboroz

  A Study to Evaluate the Efficacy and Safety of Giredestrant in Combination With Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf) Versus Phesgo in Participants With Locally Advanced or Metastatic Breast Cancer (heredERA Breast Cancer)

  NCT05296798· 3. fázis· Hoffmann-La Roche· Forrás

• Fut, nem toboroz

  A Study to Compare the Efficacy and Safety of Entrectinib and Crizotinib in Participants With Advanced or Metastatic ROS1 Non-small Cell Lung Cancer (NSCLC) With and Without Central Nervous System (CNS) Metastases

  NCT04603807· 3. fázis· Hoffmann-La Roche· Forrás

• Fut, nem toboroz

  Activity of Lorlatinib Based on ALK Resistance Mutations Detected on Blood in ALK Positive NSCLC Patients

  NCT04127110· 2. fázis· European Organisation for Research and Treatment of Cancer - EORTC· Forrás

• Fut, nem toboroz

  A Study of Adding Apalutamide to Radiotherapy and LHRH Agonist in High-Risk Patients With Hormone-Sensitive Prostate Cancer

  NCT04557059· 3. fázis· Janssen Pharmaceutica N.V., Belgium· Forrás

• Toboroz

  EORTC Metastatic Breast Cancer Module Development

  NCT07806266· University of Leeds· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Gyermekkori daganatok3 toboroz
• Akut mieloid leukémia (AML)2 toboroz
• Akut limfoid leukémia (ALL)1 toboroz
• Áttétes emlőrák1 toboroz
• Fej-nyaki daganatok1 toboroz

Lezárt vizsgálatok

• Lezárult

  RESPECT: (REsearching Stigma in PEdiatric Cancer Tool)

  NCT06470230· St. Jude Children's Research Hospital· Forrás

• Leállították

  A 3 Arm Randomized Study on Health-related QoL of Elderly Patients With Advanced Soft Tissue Sarcoma

  NCT04780464· 3. fázis· European Organisation for Research and Treatment of Cancer - EORTC· Forrás

• Lezárult

  Treatment Patterns & Clinical Outcomes of Palbociclib Combinations in HR+HER2-MBC

  NCT04937660· Pfizer· Forrás

• Lezárult

  Follow-up in Early and Locally Advanced Breast Cancer Patients

  NCT03859453· European Organisation for Research and Treatment of Cancer - EORTC· Forrás

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Akut limfoid leukémia (ALL)12 munka · 1 vizsgálat
• Hodgkin-limfóma11 munka · 0 vizsgálat
• Gyermekkori daganatok11 munka · 4 vizsgálat
• Pajzsmirigyrák9 munka · 0 vizsgálat